The breast cancer suppressor protein, BRCA1 plays an important role in mediating cell cycle arrest, apoptosis and DNA responses to DNA damage signals. In this study, we show that BRCA1 level is downregulated during UV-induced apoptosis by caspase-3 mediated cleavage. Cleavage of BRCA1 by caspase-3 produced a fragment that contained the C-terminal of the molecule. Accordingly, treatment of cells with caspase-3 inhibitor or mutation of a specific caspase-3 cleavage site (DLLD) at amino acid 1151 -1154 of BRCA1 abolished cleavage and consequential accumulation of the BRCA1 Cterminal fragment. Whereas expression of the noncleavable BRCA1 (D/A 1154) mutant conferred the resistance phenotype to UV-induced cell death, expression of the cleaved BRCA1 C-terminus induced cell death in the absence of UV. Examination of the mechanism of C-terminus-induced cell death revealed that the cleaved fragment triggers the apoptotic response through activation of BRCA1 downstream effectors, GADD45 and JNK. Altogether, results of our study demonstrate a functional role for caspase-3 mediated cleavage of BRCA1 during UV-induced apoptosis.
Introduction
Apoptosis is a normal physiological process that plays an important role in embryonic development and tissue homeostasis maintenance (Afford and Randhawa; Meier et al., 2000) . Because apoptosis is genetically programmed, its deregulation often contributes to pathologies such as tumor promotion, immunodeficiency diseases, and neurodegenerative disorders (Thompson, 1995; Yuan and Yankner, 1999) . Concerted efforts to characterize the apoptotic process have shown that, irrespective of the origin and the pathways that activate it, apoptosis proceeds through a common mechanism involving predictable, reproducible sequence of events that includes DNA fragmentation, chromatin condensation, membrane blebbing, cell shrinkage and disassembly into membrane-enclosed vesicles (Hengartner, 2000) .
Central components of the apoptotic machinery are a family of cysteine-proteases termed caspases. Caspases dismantle the cell by targeting a panoply of proteins for limited proteolysis (Earnshaw et al., 1999) . Generally synthesized as an inactive proform, they are activated by proteolytic cleavage. Out of the 14 different caspases that have been identified, caspase-3, thus far, remains the most common and important effector of apoptotic processes. Observations made in caspase-3-deficient mice indicate that this protein is necessary for specific apoptotic processes such as DNA degradation, nuclear condensation, plasma membrane blebbing, and proteolysis of certain substrates (Woo et al., 1998) . Generally, caspase-3 cleavage results in functional inactivation of its targets; however, a handful of proteins are activated by caspase-3 cleavage. For example, Poly ADP-Ribose polymerase-1 (PARP-1) when proteolyzed by caspase-3 produces a cterminal fragment that totally inhibits full-length PARP activity to allow apoptotic advancement (D'Amours et al., 2000; Kim et al., 2000) . Similarly, cleavage of protein kinase C (PKC) d and j generates a 40 kDa catalytically active fragment that when overexpressed results in events typical of apoptotic advance (Ghayur et al., 1996) . Thus, caspase-3 contributes to apoptotic progression not only through functional inactivation but also through activation of target proteins.
The breast cancer suppressor protein, BRCA1 is a multifunctional protein implicated in DNA repair, cell cycle regulation and transcription (Vijver, 1993; Yu, 2000) . BRCA1 is a 220 kDa nuclear protein, whose expression and phosphorylation is regulated in a cell cycle-dependent manner (Chen et al., 1996; Gudas et al., 1996; Ruffner and Verma, 1997) . On its Nterminus, BRCA1 contains a cysteine/histidine rich RING finger domain that mediates its binding to another RING finger containing protein, termed Bard1 (Jin et al., 1997) . The C-terminus of BRCA1 contains a duplicated globular domain, the BRCT domain, that is shared in many DNA repair proteins including XRCC1, DNA ligase III and IV, and the cell cycle checkpoint protein, Rad9 (Deng and Brodie, 2000) . Exposure to genotoxic agents such as UV and ionizing radiation induces BRCA1 phosphorylation by PI-3 kinase related family of kinases, ATM and ATR (Cortez et al., 1999; Chen, 2000) . It is generally thought that phosphorylation activates its DNA repair capability since mutations of the ATM/ATR phosphorylation site on BRCA1 abrogates its DNA repair function. A recent study showed that BRCA1 coexists with a number of DNA repair proteins including the mismatch repair (MMR) proteins MLH1, MSH6, and MSH2, the Ataxia telangiectasia mutated (ATM) protein, and the Bloom's syndrome protein (BLM), in a multiprotein complex termed BASC (BRCA1-associated genome surveillance complex) . Further, cells impaired in BRCA1 function display impaired transcription-coupled repair (TCR) of oxidative DNA damage arising from IR and H 2 O 2 exposure (Gowen et al., 1998) . Such findings support a genome protection function for BRCA1 through its DNA repair capability.
A distinct role for BRCA1 in transcriptional regulation has been proposed (Chapman and Verma, 1996; Monteiro et al., 2000) . The C-terminus of BRCA1, when fused to the GAL4 DNA binding domain activated GAL4 promoter. In transient transfection assays, BRCA1 increased p53-dependent and independent transcription from the p21 WAF1/CIP1 and GADD45 promoters (Chai et al., 1999; Jin et al., 2000) . In addition, BRCA1 caused accumulation of p53 after gamma-irradiation through transcriptional stimulation of the p53-responsive promoter, MDM2. A number of transcription regulatory proteins including ATF1, p53, BARD1, CtIP, CBP/p300, and RNA Polymerase II have been shown to interact with BRCA1 (Monteiro et al., 2000) . BRCA1 may also regulate transcription through interaction with the SWI/SNF chromatin-remodeling complex (Bochar et al., 2000) .
A major transcriptional target of BRCA1 is the DNA damage-responsive gene, GADD45. Overexpression of BRCA1 caused transcriptional stimulation of the DNA damage-responsive gene GADD45 (Harkin et al., 1999) . Studies involving high-density cDNA array screening identified many genes, including GADD45, as BRCA1-regulated genes (MacLachlan et al., 2000) . Induction of BRCA1 triggers apoptotic response in U2OS correlated well with activation of c-Jun Nterminal kinase/stress-activated protein kinase (JNK/ SAPK) a signaling pathway potentially linked to GADD45 gene family members. These findings have established a potential role for BRCA1 in apoptotic initiation through a pathway involving GADD45 and JNK. Further, BRCA1 mediated induction of GADD45 and JNK/SAPK-dependent apoptosis is shown to be p53 independent (Thangaraju et al., 2000) . Additionally, serum deprivation or calcium ionophore treatment of BRCA1 transfectants resulted in programmed cell death (Shao et al., 1996) .
A previous study determined that the breast cancer tumor suppressor protein, BRCA1 level is downregulated both at mRNA and protein level by UV-C radiation in a dose-and time-dependent manner (Fan et al., 1998) . Another study showed that the steadystate level of BRCA1 is regulated by proteolysis and that N-acetyl-leu-leu-norleucinal (ALLN), an inhibitor of the proteasome caused accumulation of BRCA1 protein (Blagosklonny et al., 1999) . In this study we show that BRCA1 is cleaved by caspase-3 during UVinduced apoptosis. Cleavage of BRCA1 by caspase-3 caused accumulation of a C-terminal 90 kDa fragment of BRCA1 that when overexpressed induced cell death in the absence of UV. Correlating well with activation of cell death response the C-terminus of BRCA1 activated GADD45/JNK signaling cascade. Conversely, expression of a non-cleavable BRCA1 mutant conferred protection against cell death and blocked GADD45 and JNK activation by UV radiation. These results identify a functional role for caspase-mediated cleavage of BRCA1 in the regulation of cell death response to UV irradiation.
Results

Cleavage of BRCA1 during UV-induced apoptosis
To assess the temporal effect of genotoxic agentinduced apoptosis on the integrity of BRCA1, HL-60 cells (a well-studied model system for apoptosis) were induced to undergo apoptosis by exposure to 60 joules/ m 2 of UV-C radiation. Induction of apoptosis was evident by the appearance of a detectable population of cells containing sub-2N complement of DNA after irradiation ( Figure 1a) . The time-dependent cleavage of the apoptotic marker proteins, caspase-3 ( Figure 1b ) and poly-ADP-polymerase (PARP) (Figure 1c ) further confirmed apoptotic induction in irradiated cells.
Immunoprecipitation followed by immunoblotting of BRCA1 revealed the presence of a *220 kDa BRCA1 band that, following UV-irradiation, displayed retarded electrophoretic migration (Figure 1d , compare lanes 1 and 2), due to UV-stimulated phosphorylation (Thomas et al., 1997) . In addition to full-length BRCA1, an immunoreactive band of *90 kDa MW was detected in UV-irradiated cells but not in control population (lane 2). Concomitant with an increase in the abundance of the 90 kDa band, a decrease in full-length Brca1 protein was also observed at 5 and 7 h post-irradiation (lanes 3 and 4). Cleavage of BRCA1 is not due to non-specific activation of proteases during lysate preparation since under the same condition cleavage of the BRCA1-related protein, BRCA2 was not observed (not shown). Together, these results indicate that BRCA1 is specifically cleaved during UV-induced apoptosis.
The detection of the 90 kDa Brca1 fragment by an antibody that recognizes the C-terminus of Brca1 (C-20) but not the N-terminus of BRCA1 (N-12) (not shown) suggested that the UV-induced cleavage results in accumulation of a 90 kDa C-terminal fragment of Brca1. To confirm this, HeLa cells ectopically expres-sing a C-terminally Flag-tagged BRCA1 were exposed to UV and its cleavage was examined. Results ( Figure  1e) showing the unambiguous recognition of the 90 kDa cleaved polypeptide by anti-FLAG antibodies in UV-irradiated cells establish the 90 kDa band as the C-terminus of BRCA1. The fate of the N-terminal fragment of BRCA1 resulting from this proteolytic cleavage is not known; however, it is possible that this fragment, which contains the RING finger domain may be targeted for degradation by the ubiquitinmediated proteosome pathway.
Cleavage of BRCA1 is mediated by caspase-3
To determine if cleavage of BRCA1 is mediated by caspase class of proteases, HL-60 cells were induced to undergo apoptosis by UV irradiation in the presence of various caspase inhibitors and cleavage was assessed. To provide direct support for the involvement of caspase-3 in BRCA1 cleavage, 35 S-methionine-labeled BRCA1 prepared by transcription-coupled translation in vitro was tested for its ability to serve as caspase-3 substrate. While abundant full-length BRCA1 was detected both in the crude reaction and after immunoprecipitation from the in vitro translated products ( Figure 3a , lanes 2 and 5) incubation with caspase-3 resulted in the appearance of a *70 kDa proteolytic fragment (Figure 3a , lanes 3 and 6). The identity of this band as a C-terminal proteolytic fragment was unambiguous since this moiety was immunoprecipitated by the anti-BRCA1 antibody (C-20) that recognizes the C-terminus. A control reaction Figure 1 Cleavage of BRCA1 during UV-induced apoptosis. HL-60 cells were exposed to UV-C (60 joules/m 2 ), collected at the indicated time points and their sub-2N DNA content was assessed by flow cytometry (a). Lysates prepared from mock and treated cells were resolved on a 10 -15% SDS -PAGE, transferred onto an Immobilon-P and probed with anti-caspase-3 (b) or PARP antibody (c). Extracts were also used for immunoprecipitation of BRCA1 followed by immunoblotting against anti-BRCA1 (d) UV-induced cleavage of C-terminally showing the cleavage of PARP by caspase-3 shows the specificity of in vitro cleavage reaction ( Figure 3b ).
Identification of the caspase-3 cleavage site in BRCA1
Previous studies established that substrates of caspase-3 are recognized and cleaved due to the presence of the consensus DXXD sequence (Earnshaw et al., 1999) . Inspection of BRCA1sequence revealed the presence of two putative caspase-3 cleavage sites (DVLD and DLLD) at amino acids positions 411 -414 and 1151 -1154, respectively (Figure 4a ). Consistent with our results concerning the digestion of BRCA1 by caspase-3 in vitro, cleavage of BRCA1 at position at 1154 is predicted to generate a fragment of *70 kDa. In order to evaluate this motif as the caspase-3 recognition site, we mutated aspartic acids at position 1151 and 1154 to alanine (designated as D/A1154). Additionally, a second mutant possessing an analogous mutation at position 411 and 414 (D/A414) was also constructed. The mutant constructs were tagged with the Flag epitope and their ability to serve as caspase-3 substrates in vivo was tested by transfection of S-labeled FLAG-tagged BRCA1 (and PARP) prepared by in vitro transcription/translation was incubated with purified caspase-3 for 90 min at 308C. The reaction products were analysed directly by 6% SDS -PAGE or used for immunoprecipitation of BRCA1 using anti-FLAG antibody and then analysed by SDS -PAGE. The gel was dried, subjected to fluorography and exposed for autoradiography (a). Cleavage of in vitro translated PARP by caspase-3 (b) death following UV treatment. Consistent with these results, wt and D/A414 BRCA1 cells showed *4.5-fold increase in caspase-3 activity following UV-irradiation (Figure 5b (Figure 5c ). Together, the results indicate that cleavage of BRCA1 is a requisite for apoptotic advancement of UV-irradiated cells.
We next examined if expression of the non-cleavable BRCA1 mutant protects cells from UV-mediated cell killing by employing a clonogenic assay. HCT 116 cells expressing low levels of wt and D/A mutants ( Figure  6b ) were exposed to low doses of UV, which induced low levels of BRCA1 cleavage, and the percentage of surviving colonies after 14 days was assessed. Under the conditions assayed, *6 -8-fold more surviving colonies were observed with the non-cleavable BRCA1 mutant than with wt or D/A 414 mutant of BRCA1 (Figure 6a,b) . The increased UV survivability of the non-cleavable mutant cells further confirmed the involvement of BRCA1 cleavage in mitogenic cell death response.
If cleavage of BRCA1 is required for apoptotic advancement then it is a reasonable expectation that the cleaved product induces apoptosis. To determine the same, cDNA constructs encoding varying Cterminal segments of BRCA1 (BE and KE; Figure  7a ) were expressed in HEK 293 cells, and their ability to promote apoptosis was examined. As control, the Nterminal NK fragment of BRCA1 was also tested. Unlike HCT 116 cells, statement of full-length BRCA1 induced robust cell death, as demonstrated by 46% increase in Annexin V positive cells (Figure 7b) . Expectedly, KE and BE fragments also induced apoptosis with equivalent efficiency. In stark contrast, expression of the NK fragment had very little effect on cell death. In agreement with these findings, KE and BE but not NK fragment transfectants displayed high levels of caspase-3 activity (Figure 7c) . Together, the results demonstrate that the C-terminus of BRCA1 contains pro-apoptotic property similar to that of fulllength BRCA1. Induction of apoptosis by the C-terminus of Brca1 occurs via GADD45/JNK pathway A study by Harkin et al. (1999) showed that apoptotic initiation by full-length BRCA1 occurs via activation of the stress-responsive gene, GADD45. Further, in transient transactivation assays, BRCA1 activated the GADD45 promoter in a p53-independent manner (Jin et al., 2000; Thangaraju et al., 2000) . Therefore, we examined if the pro-apoptotic activity of the Cterminus of BRCA1 relies, in part, on its ability to transactivate GADD45 in transient transfection assays utilizing CAT reporter under the control of GADD45 promoter (nt-994 to+1). Consistent with the report of Jin et al. (2000) , expresssion of wt BRCA1 activated (*eightfold) GADD45 promoter (Figure 8b) . Further, the C-terminal fragments, BE and KE displayed transactivation property similar to that wt-BRCA1 in that fold activation closer to eight and nine were obtained. Interestingly, despite similar levels of expression ( Figure 8a ) the D/A 1154 mutant showed significantly reduced GADD45 transactivation.
The stress-activated protein kinase JNK is another important mediator of UV-induced apoptosis (Tournier et al., 2000) . Like GADD45, a role for JNK in BRCA1-induced apoptosis is indicated by the observation that expression of a dominant negative JNK mutant abrogated BRCA1-induced apoptosis (Harkin et al., 1999) . To determine if the apparent pro- 2 ) and 12 h after exposure the cell death response was assessed by propidium iodide/Annexin V staining followed by FACS analysis. The percentage of cells displaying Annexin V staining is given (a). Lysates prepared from these cells were adjusted for equal protein concentration and caspase-3 activity was measured using a fluorogenic substrate as described in Materials and methods (b). HeLa cells transfected with wt or mutants of BRCA1 along with GFP plasmid were exposed to UV and after 12 h cells were stained with Hoechst and viewed under microscopy (c) Figure 6 Cloning efficiency of transfected clones irradiated with ultraviolet. HCT 116 cells expressing wt or D/A mutants of BRCA1 were exposed to 2, 4, 8 and 10 joules/m 2 of UV and their colony forming ability were examined as described in Materials and methods. Data represent the average percentage of colony numbers relative to that of mock-irradiated control cells (a). Cell extracts were formed and analysed for recombinant BRCA1 expression by immunoblotting the lysate against anti-Flag antibody (b) apoptotic activity of the C-terminal fragments involves JNK activation, cells transfected with wt, D/A, or truncation mutants of BRCA1 were assayed for activation of JNK by immunoblotting the lysate with an antibody that recognizes dually (Threonine and Tyrosine) phosphorylated active JNK. The striking correlation of the KE and BE fragment to induce apoptosis and to activate JNK, as shown in Figure 8c , provide further support for the involvement of the cleaved C-terminus in the apoptotic advancement of UV-irradiated cells.
Discussion
In this study, we demonstrate the cleavage and the consequential downregulation of full-length BRCA1 by caspase-3 during UV-induced apoptosis. Cleavage of BRCA1 by caspase-3 produces a fragment that contains the C-terminal portion of the molecule. Several lines of evidence indicate that cleavage is caspase-3 mediated. First, treatment of cells with caspase-3 inhibitor blocked BRCA1 cleavage. Second, incubation of full-length BRCA1 with caspase-3 in vitro generated a C-terminal fragment of *70 kDa. The lower MW of the cleavage product could be due to the lack of extensive phosphorylation that BRCA1 undergoes on its C-terminus after UV irradiation in vivo. Finally, mutation of a caspase-3 specific cleavage site (D/A1154) rendered BRCA1 non-cleavable.
Overstatement of BRCA1 results in induction of high levels of spontaneous apoptosis in U2OS cells (Harkin et al., 1999) . Additionally, in ovarian and prostate cancer cell lines, BRCA1 enhanced apoptosis induced by other stimuli such as growth factor withdrawal, substratum detachment, ionizing radiation (Thangaraju et al., 2000) . While induction of apoptosis by full-length BRCA1 suggests a more upstream role for BRCA1, results presented here are consistent with BRCA1 acting downstream of caspase-3. It should be noted, however, that forced expression often causes accumulation of non-physiological levels and cells respond to such toxic levels of proteins by mounting a death response. Unlike overexpression-induced apoptosis, UV-induced BRCA1 cleavage and the consequential accumulation of its C-terminal fragment, as reported here, are observed in cells carrying physiological levels of BRCA1. Of note, low levels of the cleaved C-terminus were observed during overexpression-induced apoptosis (not shown). Thus, low levels of caspase-3, activated during overexpression may cause cleavage of BRCA1 ultimately leading to the activation of cell death program. Moreover, the increased sensitivity of BRCA1-mutated cells (HCC1937) to UV and other DNA damaging agents suggest a role for BRCA1 in DNA repair rather than triggering the apoptotic response to DNA damage (Gowen et al., 1998) . Further, our observation that BRCA1 is cleaved during apoptosis is also consistent with cleavage and inactivation of a number of DNA repair proteins including DNA-PK and PARP observed during activation of cell death program (Afford and Randhawa, 2000; Earnshaw et al., 1999) . Together, such findings argue the presence of BRCA1 downstream of caspase-3 in the UV induced cell death pathway.
Role of BRCA1 cleavage in DNA repair and cell cycle
What is the functional consequence of caspase-3 cleaved BRCA1? As mentioned above, abrogation of BRCA1's repair function through caspase-3 mediated cleavage could render cells that sustain extensive damage to cell death rather than be transformed. Presently, the mechanism by which BRCA1 participates in DNA repair is not clear. However, one study determined that the N-terminus of BRCA1 binds DNA repair proteins such as the mammalian RecA homolog Rad51 and its binding partner Rad52 (Yu, 2000) and that this interaction with Rad family members may mediate its repair functions. A more recent study determined that the inherent property of BRCA1 to bind branched DNA structures and form protein-DNA complexes cooperatively between multiple DNA strands may be important for its role in DNA repair (Paull et al., 2001) . The coexistence of BRCA1 with a number of repair proteins further suggests that BRCA1 may co-ordinate multiple activities during DNA repair . These findings raise the possibility that cleavage of BRCA1 may render it incapable of binding to structured DNA or repair proteins neutralizing its role in DNA repair.
Beyond its documented role in DNA repair and apoptosis, BRCA1 has been implicated in establishment of the G2/M cell cycle checkpoint following DNA damage. In support of this view, cells from BRCA1-deficient mice display defective G2/M arrest response to DNA damaging agent treatment (Xu et al., 1999) . Interestingly, expression of a C-terminal fragment of BRCA1 (amino acids 1293 -1863) abrogated colchicine-induced G2/M arrest (Larson et al., 1997) . The latter observation suggests a dominant negative role for the C-terminal domain in the G2/M arrest response. Additionally, a number of cell cycle regulatory proteins, including RB and p21, are cleaved during apoptosis and this event is thought to abolish the roles these proteins play in cell cycle advance (Earnshaw et al., 1999; Walter et al., 1998) . Thus, an exit from cell cycle arrest that may be necessary for the initiation of apoptosis may also be accomplished by cleavage.
Role of BRCA1 cleavage in UV-induced apoptosis
The apoptotic resistance phenotype displayed by D/ A1154 mutant suggests that cleavage of BRCA1 is a requisite for apoptotic progression. Consistent with this result, expression of the cleaved C-terminus but not the N-terminus induced apoptosis. In fact, expression of the NK fragment protected cells from cell death triggered by UV exposure. Studies by Thangaraju et al. (2000) showed an anti-apoptotic role for the Nterminus of BRCA1 since a truncation mutant of BRCA1 lacking the C-terminus suppressed apoptosis, including spontaneous apoptosis. Therefore, cleavage of BRCA1 may activate the pro-apoptotic function of the C-terminus through removal of the anti-apoptotic N-terminus. Additionally, BRCA1 cleavage could activate its GADD45 transcriptional stimulatory function that could potentially contribute to apoptosis. Although the precise role of BRCA1-induced GADD45 transcription in UV-induced apoptosis remains to be elucidated, studies by Rishi et al. (1999) showed that post-transcriptional upregulation of GADD45 correlates with apoptotic induction by synthetic retinoids in both human breast and lung carcinoma cells. Furthermore, GADD45 upregulation is observed during apoptosis induced by agents that cause endoplasmic reticulum stress (Sheikh et al., 2000) . Such findings support the GADD45 transcriptional stimulatory function as a mediator of BRCA1 C-terminus-induced apoptosis. In addition to GADD45 transactivation, forced expression of the C-terminal fragment activated JNK, as judged by an increased abundance of dually (tyrosine and threonine) phosphorylated JNK. This observation, when taken with the finding that targeted disruptions of all functional JNK genes rendered embryonic fibroblasts refractory to UV-induced apoptosis (Tournier et al., 2000) , suggests that BRCA1 Cterminus-induced apoptosis involves catalytic activation of JNK activity.
In summary, evidence provided here shows that BRCA1 is downregulated during UV-induced apoptosis by caspase-3 mediated cleavage. While expression of a non-cleavable mutant of BRCA1 raised the cellular resistance to UV-induced cell death, the C-terminal fragment activated the cell death program in the absence of UV irradiation. Correlating these findings well, the C-terminus activated the GADD45/JNK pathway whereas the non-cleavable mutant downregulated it. These data support a functional role for caspase-3 mediated cleavage of BRCA1 in the regulation of cell death response to UV irradiation.
Materials and methods
Cell culture and reagents
HeLa, HL-60, HEK293 and HCT 116 cells were purchased from American Tissue Type Collection (ATCC) and maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% heat inactivated fetal bovine serum (FBS) or RPMI containing 15% FBS. Stable transfectants were obtained by transfecting HCT 116 cells with 3 -5 mg of plasmid using lipofectamine and selecting with G418 (at a concentration of 0.4 mg/ml) or Zeomycin as per the manufacturer's protocol. Leupeptin, aprotinin and phenylmethylsulf-onyl fluoride (PMSF) were purchased from Sigma. Caspase inhibitors, ZVED-fmk, LEHD-fmk, IETD-fmk, and VETD-fmk were purchased from BioMol. Anti-BRCA1 (C20 and N-17), anti-caspase-3 (H277), and anti-PARP (F2) were purchased from Santa Cruz Biotechnology. Anti-Flag (M2) antibody was from Sigma-Aldrich. Horseradish peroxidaseconjugated goat anti-rabbit and anti-mouse were purchased from Bio-Rad. The fluorogenic caspase-3 substrate Ac-DEVD-AFC (7-amino-4-trifluoromethylcoumarin) was obtained from Pharmingen.
Plasmids
The BRCA1 C-terminal fragments KE and BE were constructed by digestion of a wildtype (wt) BRCA1 cDNA clone with KpnI and EcoRI (KE fragment) or with BamHI and EcoRI (BE fragment) and subcloning the released fragments into pcDNA4 His-Max vector from Invitrogen. The BRCA1 N-terminal fragment, NK was obtained by digestion with HindII and KpnI. D/A 414 and D/A 1154 BRCA1 mutants were created utilizing the Gene Editor mutagenesis system as described by the manufacturer (Promega). The mutagenic oligonucleotides used for the creation of D/A mutants were 5-GCCAAAGTAGCTGC-TGTATTGGCCGTTCTAAATGAGGTAG-3 for D414A and 5-GAGACACCTGCCCTGTTAGCTGGTGAAATAA-AGG-3 for D/A1154 mutant.
Immunofluorescence
HeLa cells were plated at a density of 2610 5 cells/plate and transfected with Flag-tagged BRCA1 by lipofectaminemediated trasfection. Transfection efficiency was monitored by including 0.5 mg of pEGFP plasmid and determining the percentage of cells expressing EGFP by fluorescence microscopy (Nikon). Thirty-six hours post-infection, cells were either mock-treated or exposed to UV (60 joules/cm 2 ) and collected at the indicated time points. Cells were fixed on cover slips with 4% formaldehyde in PBS and stained with Hoechst stain. Cover slips were then mounted onto slides and apoptotic morphology was examined under a Ziess fluorescence microscope.
Apoptosis
Cultures of cells at *70% confluency were exposed to UV-C (60 joules/m 2 ) and harvested at the indicated time points. Cells were washed in phosphate-buffered saline (PBS), and fixed with ice-cold 70% ethanol overnight. Cells were then suspended in 16PBS containing RNase A (20 mg/ml) and propidium iodide (20 mg/ml). Fluorescence-activated cell sorting (FACS) was performed with a Becton Dickinson FACSort apparatus and used to quantitate the apoptotic population based on DNA levels. For assessing phosphatidylserine redistribution, cells were incubated with 0.1 mM Fluorescein-conjugated human Annexin V (Pharmingen) in PBS containing 2% fetal bovine serum for 15 min at 378C prior to flow-cytometric analysis.
Cleavage assays
Full-length BRCA1 was translated using TNT-reticulocyte lysate system (Promega) with T7 RNA polymerase in the presence of 35 S-methionine. Five ml of the translation mix was incubated with 1 ml (30 units) of purified caspase-3 (BioMol) in a 20 ml reaction buffer containing 100 mM HEPES pH 7.5, 10% sucrose and 0.1% 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate. Following incubation at 308C for 2 h, labeled proteins were resolved by SDS-polyacrylamide gel electrophoresis followed by fluorography.
Caspase-3 activity
Caspase activity in whole-cell extracts was determined by treating cells with a solution containing 50 mM HEPES (pH 7.4), 1% Triton X-100, 5 mM EDTA, and 2 mM DTT and incubating them with 50 mM acetyl-Asp-Glu-Val-Asp-7-amino-4-methylcoumarin (AcDEVD-amc) for 30 min at 378C as described (Tournier et al., 2000) . Fluorescence in the linear range of DEVDase activity was measured with a plate reader (Tecan).
Immunoprecipitation and immunoblotting
At the indicated time points, cells were lysed in 16lysis buffer containing 25 mM Tris pH 7.6, 150 mM NaCl, 1 mM EDTA, 1 mM NaF, 1% Triton X-100, 1 mM PMSF, 1 mM DTT, 1 mM sodium orthovanadate, and 1 mg/ml of pepstatin, leupeptin, and aprotinin. Lysate was centrifuged for 30 min at 13 000 r.p.m. Anti-BRCA1 (C-20 or N-17) or anti-Flag antibody was added at a concentration of 0.1 mg/ml to the supernatant and immune-complexes were collected by binding to 50 ml of Protein A-Sepharose beads (5 mg/ml). The beads were washed twice with 16lysis buffer containing 500 mM NaCl, twice with lysis buffer containing 25 mM NaCl and twice with 16lysis buffer. Equal volume of SDS sample buffer was added and the samples were resolved by SDS -PAGE on 6% acrylamide gels. Proteins were transferred onto Immobilon-P (Millipore) membrane using a Bio-Rad semidry transfer apparatus. Membranes were then blocked in PBS containing 0.5% Tween-20 and 5% dry milk for 1 h at RT and probed with primary and secondary antibody. Blots were developed using Enhanced Chemiluminescence from NEN.
UV survival assays
HCT 116 cells expressing wt and mutants of BRCA1 were plated at a confluency of 1610 5 cells per well in 60-mm plates and exposed to varying doses of UV radiation (2, 4, 6 and 10 joules/m 2 ) then plated in 100-mm tissue culture dishes. The cultures were maintained until the surviving cells formed colonies. The colonies that survived after incubation were then stained with crystal violet, counted, and relative colony numbers were obtained.
Abbreviations UV, Ultraviolet; DSB, Double strand break; FACS, fluorescence-activated cell sorting; PI, propidium iodide; PAGE, polyacrylamide gel electrophoresis
